Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1691679

Cover Image

PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1691679

Innovations and Growth Opportunities in Electroceuticals for Chronic Diseases

PUBLISHED:
PAGES: 62 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Web Access (Regional License)
USD 4950

Add to Cart

Transforming Chronic Disease Management Through Advanced Neuromodulation Technologies

Electroceuticals is a rapidly growing field that is pursuing new and innovative solutions to overcome challenges in treating various pain and neurological disorders. Emerging technologies in these areas attract significant interest because of their potential to revolutionize the field, creating promising opportunities for technology developers in the electroceutical industry for product development. However, the innovations face significant challenges, including non-selectivity, invasiveness, open-loop, and risk of data breach. As a result, most R&D activities in emerging electroceutical technologies mainly focus on incorporating AI in wearables.

Questions this report answers: What are the emerging technologies gaining prominence in pain and neurological disorders management in the electroceutical space? What are the advantages and disadvantages driving R&D efforts in these modalities? Who are the major stakeholders targeting the adoption of these emerging modalities? What are the growth opportunities for electroceuticals in pain and neurological disorder management and the MedTech industry in the future?

With the rise in non-addictive, non-opioid-based personalized treatment approaches, there is an adoption shift from traditional reactive pharmaceuticals to modern preventative electroceuticals. Compared to pharmaceutical drugs, these have enabled early intervention and long-term disease management. The primary focus of the study is to identify the emerging technologies witnessing adoption across the electroceutical industry that will surpass conventional drugs and pharmaceuticals. Because of the wide adoption of Spinal Cord Stimulation, Peripheral Nerve Stimulation, and Transcranial Magnetic Stimulation for treating chronic pain and neurological conditions, respectively, and the emerging concepts of wearable electroceutical devices, closed-loop neuromodulation, and personalization, this study discusses the potential advantages and disadvantages of emerging technologies in the industry.

Product Code: DB18

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on Electroceuticals for the Chronic Diseases Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Research Methodology

Growth Opportunity Analysis

  • Overview of Electroceuticals
  • Key Neuromodulation Techniques
  • Key Players
  • Tech Invasiveness vs Tech Adoption
  • Electroceuticals Ecosystem
  • FDA-approved Electroceuticals for Commercial Use (2021?2024)
  • Challenges of Electroceutical Devices
  • Scope of Analysis
  • Segmentation

Growth Generator

  • Growth Drivers
  • Growth Restraints
  • Snapshot of SWOT Analysis

Technology Analysis & Companies to Action

  • AI Techniques in Pain Management Electroceuticals
  • Companies to Action for Pain Management
  • Patent Database Analysis for SCS and PNS Electroceuticals
  • Challenges and Opportunities in Personalizing Closed-loop TMS
  • Companies to Action for Neurological Disorders Treatment
  • Patent Database Analysis for TMS Electroceuticals
  • Personalized, Adaptive, Hybrid, and Wearable Devices are Key Technology Trends
  • Geographic Distribution of Companies and Start-ups
  • Evolving Technologies in the Electroceuticals Space

Industry Snapshot

  • Funding Analysis 2021?2024: Nalu Medical Grabs Maximum Funding
  • M&A Analysis 2021?2024: TMS Drives the Acquisition Spree
  • Evolving Industry Trends in the Electroceuticals Space

Growth Opportunity Universe in Electroceuticals for Chronic Diseases

  • Growth Opportunity 1: Injectable Electrodes and Neuromodulation Textiles can Mitigate Lead Migration and Electrode Displacement
  • Growth Opportunity 2: Miniaturization, Microetching, Flexible Electronics, and Ultra-low Power Operations Improve Usability
  • Growth Opportunity 3: Promoting Partnerships with Technology Developers to Create a Centralized Database for Neural Circuits

Appendix

  • Technology Readiness Levels (TRL): Explanation

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!